Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 8 | 2022 | 366 | 1.720 |
Why?
|
| Vena Cava Filters | 3 | 2021 | 18 | 1.420 |
Why?
|
| Prosthesis Implantation | 3 | 2021 | 83 | 1.190 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2022 | 134 | 0.930 |
Why?
|
| Blood Vessel Prosthesis Implantation | 4 | 2022 | 186 | 0.920 |
Why?
|
| Vena Cava, Inferior | 2 | 2021 | 41 | 0.890 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2022 | 134 | 0.840 |
Why?
|
| Venous Thrombosis | 2 | 2021 | 125 | 0.830 |
Why?
|
| Vascular Surgical Procedures | 3 | 2021 | 168 | 0.810 |
Why?
|
| Heart-Assist Devices | 5 | 2012 | 221 | 0.800 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 117 | 0.700 |
Why?
|
| Ischemia | 2 | 2022 | 229 | 0.660 |
Why?
|
| Pulmonary Embolism | 3 | 2017 | 253 | 0.660 |
Why?
|
| Lower Extremity | 2 | 2022 | 153 | 0.660 |
Why?
|
| Respiratory Tract Diseases | 2 | 2016 | 43 | 0.640 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2017 | 139 | 0.640 |
Why?
|
| Retrospective Studies | 18 | 2022 | 7277 | 0.570 |
Why?
|
| Treatment Outcome | 14 | 2022 | 7029 | 0.550 |
Why?
|
| Respiration | 1 | 2016 | 91 | 0.540 |
Why?
|
| Prosthesis-Related Infections | 2 | 2016 | 70 | 0.530 |
Why?
|
| Absorbable Implants | 1 | 2016 | 29 | 0.530 |
Why?
|
| Heart Failure | 5 | 2012 | 1180 | 0.530 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 136 | 0.520 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2016 | 54 | 0.520 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2015 | 50 | 0.510 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 83 | 0.510 |
Why?
|
| Drug Carriers | 1 | 2016 | 90 | 0.510 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 191 | 0.490 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2016 | 182 | 0.480 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 107 | 0.480 |
Why?
|
| Risk Factors | 12 | 2022 | 5731 | 0.470 |
Why?
|
| Time Factors | 9 | 2021 | 4655 | 0.470 |
Why?
|
| Quality Improvement | 1 | 2016 | 413 | 0.420 |
Why?
|
| Spinal Cord Ischemia | 3 | 2022 | 21 | 0.420 |
Why?
|
| Lung | 1 | 2016 | 849 | 0.390 |
Why?
|
| Databases, Factual | 6 | 2021 | 622 | 0.390 |
Why?
|
| Aged | 15 | 2021 | 14862 | 0.370 |
Why?
|
| Middle Aged | 17 | 2021 | 21147 | 0.350 |
Why?
|
| Aortic Diseases | 2 | 2022 | 113 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 1026 | 0.330 |
Why?
|
| Postoperative Complications | 4 | 2019 | 1615 | 0.290 |
Why?
|
| Risk Assessment | 6 | 2021 | 2007 | 0.290 |
Why?
|
| Male | 17 | 2021 | 37321 | 0.270 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 4848 | 0.260 |
Why?
|
| Female | 17 | 2021 | 38074 | 0.260 |
Why?
|
| Acute Disease | 4 | 2017 | 658 | 0.250 |
Why?
|
| Pennsylvania | 3 | 2016 | 46 | 0.250 |
Why?
|
| Humans | 21 | 2022 | 68618 | 0.240 |
Why?
|
| Device Removal | 2 | 2016 | 100 | 0.240 |
Why?
|
| Patient Discharge | 2 | 2017 | 294 | 0.240 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 546 | 0.220 |
Why?
|
| Hospital Mortality | 4 | 2017 | 384 | 0.210 |
Why?
|
| Incidence | 4 | 2019 | 1603 | 0.210 |
Why?
|
| Intermittent Claudication | 1 | 2022 | 31 | 0.210 |
Why?
|
| Femoral Artery | 1 | 2022 | 139 | 0.200 |
Why?
|
| Scholarly Communication | 1 | 2021 | 2 | 0.200 |
Why?
|
| Prosthesis Design | 2 | 2021 | 301 | 0.200 |
Why?
|
| Superior Sagittal Sinus | 1 | 2021 | 8 | 0.190 |
Why?
|
| Logistic Models | 4 | 2017 | 1420 | 0.190 |
Why?
|
| United States | 5 | 2021 | 7367 | 0.190 |
Why?
|
| Canada | 1 | 2021 | 267 | 0.180 |
Why?
|
| Intracranial Hypertension | 1 | 2021 | 53 | 0.180 |
Why?
|
| Social Media | 1 | 2021 | 59 | 0.180 |
Why?
|
| Celiac Artery | 1 | 2020 | 12 | 0.180 |
Why?
|
| Mesenteric Ischemia | 1 | 2020 | 8 | 0.180 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2020 | 20 | 0.180 |
Why?
|
| Reoperation | 3 | 2019 | 467 | 0.180 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 212 | 0.170 |
Why?
|
| Young Adult | 4 | 2015 | 5717 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 373 | 0.160 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 150 | 0.150 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 211 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2016 | 880 | 0.150 |
Why?
|
| Length of Stay | 2 | 2019 | 780 | 0.150 |
Why?
|
| Airway Extubation | 1 | 2017 | 17 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 504 | 0.140 |
Why?
|
| Heart Transplantation | 2 | 2010 | 328 | 0.140 |
Why?
|
| Skilled Nursing Facilities | 1 | 2016 | 30 | 0.140 |
Why?
|
| Angioplasty | 1 | 2017 | 118 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2017 | 117 | 0.130 |
Why?
|
| Debridement | 1 | 2016 | 55 | 0.130 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 77 | 0.130 |
Why?
|
| Gentamicins | 1 | 2016 | 68 | 0.130 |
Why?
|
| Limb Salvage | 1 | 2016 | 39 | 0.130 |
Why?
|
| Vancomycin | 1 | 2016 | 60 | 0.130 |
Why?
|
| Rifampin | 1 | 2016 | 45 | 0.130 |
Why?
|
| Aorta | 1 | 2017 | 316 | 0.130 |
Why?
|
| Survival Rate | 3 | 2019 | 1056 | 0.130 |
Why?
|
| Vascular Patency | 1 | 2015 | 122 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 1465 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2016 | 304 | 0.130 |
Why?
|
| Adult | 7 | 2015 | 21403 | 0.120 |
Why?
|
| Treatment Failure | 2 | 2017 | 216 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 281 | 0.120 |
Why?
|
| Hemorrhage | 2 | 2017 | 328 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2016 | 326 | 0.110 |
Why?
|
| Adolescent | 2 | 2015 | 8912 | 0.110 |
Why?
|
| Multiple Organ Failure | 1 | 2012 | 36 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2012 | 60 | 0.100 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 133 | 0.100 |
Why?
|
| Cause of Death | 1 | 2012 | 241 | 0.100 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 792 | 0.090 |
Why?
|
| Viscera | 1 | 2010 | 16 | 0.090 |
Why?
|
| Digestive System Diseases | 1 | 2010 | 16 | 0.090 |
Why?
|
| Abdominal Wall | 1 | 2010 | 20 | 0.090 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2009 | 13 | 0.090 |
Why?
|
| Abdominal Injuries | 1 | 2010 | 60 | 0.080 |
Why?
|
| Weight Loss | 1 | 2011 | 319 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2009 | 130 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 500 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 369 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2012 | 2358 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2010 | 307 | 0.070 |
Why?
|
| Registries | 3 | 2019 | 733 | 0.070 |
Why?
|
| Propensity Score | 2 | 2017 | 117 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 332 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1046 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2012 | 714 | 0.060 |
Why?
|
| Obesity | 1 | 2011 | 1076 | 0.060 |
Why?
|
| Prognosis | 3 | 2017 | 2093 | 0.060 |
Why?
|
| Attitude to Computers | 1 | 2021 | 38 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2022 | 120 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2021 | 36 | 0.050 |
Why?
|
| Conflict of Interest | 1 | 2021 | 48 | 0.050 |
Why?
|
| Benchmarking | 1 | 2021 | 91 | 0.050 |
Why?
|
| Jugular Veins | 1 | 2021 | 37 | 0.050 |
Why?
|
| Consensus | 1 | 2021 | 211 | 0.050 |
Why?
|
| Aspirin | 1 | 2022 | 295 | 0.050 |
Why?
|
| Informed Consent | 1 | 2021 | 127 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2020 | 11 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2021 | 403 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 442 | 0.040 |
Why?
|
| Retreatment | 1 | 2017 | 59 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2017 | 95 | 0.030 |
Why?
|
| Stents | 1 | 2021 | 657 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 99 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 119 | 0.030 |
Why?
|
| Heparin | 1 | 2017 | 205 | 0.030 |
Why?
|
| Pneumonia | 1 | 2017 | 110 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 767 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 3259 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 233 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 296 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 377 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 378 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 1266 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 1426 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1864 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 392 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1040 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 191 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 245 | 0.020 |
Why?
|
| SEER Program | 1 | 2009 | 153 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2009 | 274 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 349 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 274 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 320 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 2009 | 129 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 536 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2012 | 448 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2010 | 168 | 0.020 |
Why?
|
| Stroke | 1 | 2021 | 2163 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 867 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1753 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2012 | 738 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 800 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1174 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 446 | 0.020 |
Why?
|